CBD Shows Potential for Reducing Anxiety in Women with Advanced Breast Cancer

A recent phase II clinical trial has explored the potential of cannabidiol查看药品详情 (CBD查看药品详情) to alleviate anxiety (搜索)搜索该疾病 in women with advanced breast cancer (搜索)搜索该疾病 undergoing scans to assess tumor burden. Conducted by researchers at Dana-Farber Cancer Institute查看公司主页 and Mass General Brigham (搜索)搜索该词条, the study, published in JAMA Network Open, investigated whether a single 400 mg oral dose of CBD could reduce anxiety levels compared to a placebo.

Study Design and Patient Population

The trial involved 50 women with advanced breast cancer (搜索)搜索该疾病 and clinical anxiety (搜索)搜索该疾病. Participants were randomized to receive either 400 mg of CBD查看药品详情 or a placebo prior to a scheduled scan. Anxiety levels were measured using the Visual Analog Mood Scale (VAMS) before and 2-4 hours after ingestion of the study drug. The primary outcome was the change in anxiety scores within 48 hours before the cancer scan.

Key Findings

While the study did not meet its primary endpoint of a statistically significant difference in anxiety (搜索)搜索该疾病 change scores between the CBD查看药品详情 and placebo groups, researchers observed that anxiety levels were significantly lower 2-4 hours after CBD ingestion. Specifically, the mean change in the 'afraid' score on the VAMS was numerically greater in the CBD arm (-19) compared to the placebo arm (-15), although this difference did not reach statistical significance. However, the 'afraid' component score was numerically lower at 2-4 hours after CBD ingestion in the intervention arm, at 51.5, vs 58 in the control arm.

Notably, no adverse effects of more than mild severity were observed, highlighting the safety of CBD查看药品详情 in this patient population.

Implications and Future Directions

"Our results lay the groundwork for larger, more definitive trials testing CBD查看药品详情 in patients with breast cancer (搜索)搜索该疾病 and other cancers as a way of reducing anxiety (搜索)搜索该疾病," said co-first author Peter Chai, MD, of the Department of Emergency Medicine at Brigham and Women's Hospital.

The findings suggest that CBD查看药品详情 may possess anxiolytic properties in women with advanced breast cancer (搜索)搜索该疾病, warranting further investigation. Researchers emphasize the need for larger, well-controlled trials to confirm these results and explore the optimal dosing and administration of CBD for anxiety (搜索)搜索该疾病 management in cancer patients. Future studies should also consider including only oncology patients with moderate to severe anxiety, as this may improve the ability to detect a significant effect of CBD.

"We believe these signals are sufficiently intriguing to justify continued exploration of CBD查看药品详情 as a safe and possibly effective therapy for cancer-related anxiety (搜索)搜索该疾病," the researchers concluded.